Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GJB2 | P29033 | 4/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22544953 | 0.81 | CA2 (0.31) | — | |
| SCHEMBL26216223 | 0.77 | GJB2 (0.31) | GJB2 | |
| SCHEMBL15889754 | 0.76 | ALDH1A1 (0.33) | — | |
| SCHEMBL14925559 | 0.74 | GJB2 (0.39) | GJB2 | |
| SCHEMBL14925558 | 0.72 | LGALS8 (0.40) | — | |
| SCHEMBL15889755 | 0.72 | — | — | |
| SCHEMBL26216225 | 0.71 | SSTR1 (0.32) | — | |
| SCHEMBL12394539 | 0.71 | GJB2 (0.31) | GJB2 | |
| SCHEMBL14366120 | 0.69 | CA2 (0.33) | — | |
| SCHEMBL16442179 | 0.69 | LGALS8 (0.35) | GJB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9468206-B2 | Lactofen and dicamba diglycol amine liquid formulations | VALENT U.S.A., CORPORATION (US) | 2016-10-18 | — | — | US | disclosed |
| US-20160184193-A1 | ACOUSTICALLY-ACTIVATED COSMETIC HYDROGELS | L'OREAL (FR) | 2016-06-30 | — | — | US | disclosed |
| US-20160183518-A1 | LACTOFEN AND DICAMBA DIGLYCOL AMINE LIQUID FORMULATIONS | VALENT U.S.A., CORPORATION | 2016-06-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160184193-A1 | ACOUSTICALLY-ACTIVATED COSMETIC HYDROGELS | CUTA, SHH, CRYAA | GJB2 751/4885 |
| US-20160183518-A1 | LACTOFEN AND DICAMBA DIGLYCOL AMINE LIQUID FORMULATIONS | SLC27A1, SLC27A2, ACSL5 | GJB2 2853/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.